Development of renal and iliac aneurysms in a child with generalized infantile myofibromatosis

Benoit Brasseur1, Christophe F Chantrain, Nathalie Godefroid

  • 1Department of Pediatric Hematology and Oncology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Avenue Hippocrate 10, Brussels, Belgium.

Insights

Infantile myofibromatosis can cause severe hypertension and renal artery issues in infants. Chemotherapy helped tumors regress, but artery dilations developed, suggesting a link to fibromuscular dysplasia.

Area of Science:

  • Pediatric Oncology
  • Vascular Biology
  • Rare Diseases

Background:

  • Infantile myofibromatosis is a rare mesenchymal tumor affecting infants.
  • It can manifest with widespread tumors impacting various organs, including the kidneys.
  • Severe hypertension is a potential complication, particularly with renal involvement.

Observation:

  • A 3-week-old infant presented with severe hypertension due to generalized infantile myofibromatosis.
  • The infant received chemotherapy, leading to tumor regression.
  • Aneurysmal dilations of renal and iliac arteries developed during treatment, mimicking fibromuscular dysplasia.

Findings:

  • Successful chemotherapy treatment for infantile myofibromatosis.
  • Development of vascular abnormalities (aneurysmal dilations) post-treatment.
  • Potential association between infantile myofibromatosis and fibromuscular dysplasia.

Implications:

  • Highlights the importance of monitoring vascular health in infants with infantile myofibromatosis.
  • Suggests a possible shared mesenchymal origin or pathway between these two conditions.
  • Warrants further research into the relationship between infantile myofibromatosis and fibromuscular dysplasia.